07/09/2025
4:32 PM | Aptevo Therapeutics (Issuer)
Huebner Dirk (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/08/2025
1:11 PM | Aptevo Therapeutics (Subject)
YA II PN, Ltd. (Filed by)
| Form SCHEDULE 13G | |
07/07/2025
11:11 AM | Aptevo Therapeutics (Filer)
| Form DEF 14A | |
07/03/2025
3:15 PM | Aptevo Therapeutics (Filer)
| Form ARS | |
06/25/2025
3:30 PM | Aptevo Therapeutics (Subject)
BIGGER CAPITAL FUND L P (Filed by)
| Form SCHEDULE 13G | |
06/25/2025
3:38 PM | Aptevo Therapeutics (Subject)
INTRACOASTAL CAPITAL, LLC (Filed by)
| Form SCHEDULE 13G | |
06/23/2025
4:32 PM | Aptevo Therapeutics (Filer)
| Form PRE 14A | |
06/23/2025
3:05 PM | Aptevo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/23/2025
3:07 PM | Aptevo Therapeutics (Subject)
L1 Capital Global Opportunities Master Fund, Ltd. (Filed by)
| Form SCHEDULE 13G/A | |
06/23/2025
3:08 PM | Aptevo Therapeutics (Subject)
L1 Capital Global Opportunities Master Fund, Ltd. (Filed by)
| Form SCHEDULE 13G | |
06/20/2025
4:15 PM | Aptevo Therapeutics (Filer)
| Form 424B5 | |
Get the Latest News and Ratings for APVO and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Aptevo Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
06/20/2025
4:21 PM | Aptevo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/20/2025
8:00 AM | Aptevo Therapeutics (Filer)
| Form 424B4 | |
06/19/2025
11:15 PM | Aptevo Therapeutics (Filer)
| Form EFFECT | |
06/18/2025
1:30 PM | Aptevo Therapeutics (Filer)
| Form S-1MEF | |
06/16/2025
7:15 AM | Aptevo Therapeutics (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
05/28/2025
3:05 PM | Aptevo Therapeutics (Filer)
| Form 424B3 | |
05/23/2025
4:10 PM | Aptevo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/22/2025
11:15 PM | Aptevo Therapeutics (Filer)
| Form EFFECT | |
05/22/2025
4:29 PM | Aptevo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/22/2025
3:15 PM | Aptevo Therapeutics (Filer)
| Form 424B5 | |
05/15/2025
3:05 PM | Aptevo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/13/2025
4:30 PM | Aptevo Therapeutics (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
05/13/2025
7:08 AM | Aptevo Therapeutics (Filer)
| Form RW | |
05/13/2025
7:08 AM | Aptevo Therapeutics (Filer)
| Form RW | |
04/29/2025
4:00 PM | Aptevo Therapeutics (Filer)
| Form 424B5 | |
04/28/2025
7:01 AM | Aptevo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/28/2025
7:15 AM | Aptevo Therapeutics (Filer)
| Form 424B4 | |
04/18/2025
11:22 AM | Aptevo Therapeutics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
04/10/2025
4:06 PM | Aptevo Therapeutics (Filer)
| Form PRE 14A | |
04/10/2025
9:14 AM | Aptevo Therapeutics (Subject)
CVI Investments, Inc. (Filed by)
| Form SCHEDULE 13G | |
04/09/2025
4:31 PM | Aptevo Therapeutics (Subject)
INTRACOASTAL CAPITAL, LLC (Filed by)
| Form SCHEDULE 13G | |
04/08/2025
7:00 PM | Aptevo Therapeutics (Subject)
BIGGER CAPITAL FUND L P (Filed by)
| Form SCHEDULE 13G | |
04/07/2025
3:51 PM | Aptevo Therapeutics (Subject)
L1 Capital Global Opportunities Master Fund, Ltd. (Filed by)
| Form SCHEDULE 13G | |
04/04/2025
3:15 PM | Aptevo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/04/2025
9:10 AM | Aptevo Therapeutics (Filer)
| Form 424B4 | |
04/01/2025
5:51 AM | Aptevo Therapeutics (Filer)
| Form S-1/A | |
03/27/2025
4:14 PM | Aptevo Therapeutics (Filer)
| Form S-1/A | |
03/27/2025
6:23 AM | Aptevo Therapeutics (Filer)
| Form S-1/A | |
03/25/2025
5:42 AM | Aptevo Therapeutics (Filer)
| Form S-1/A | |
03/20/2025
7:44 AM | Aptevo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Revolutionary AI Tech Targets Early Diabetic Blindness Detection FDA Trial Underway (Ad) Tiny Stock, Massive Potential— this company’s AI platform is a game changer for healthcare! Discover how this tiny tech firm is using AI in healthcare |
03/03/2025
5:12 AM | Aptevo Therapeutics (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
02/26/2025
11:15 PM | Aptevo Therapeutics (Filer)
| Form EFFECT | |
02/14/2025
7:50 AM | Aptevo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2025
7:52 AM | Aptevo Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/11/2025
7:37 AM | Aptevo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/10/2025
5:58 PM | Aptevo Therapeutics (Subject)
Hudson Bay Capital Management LP (Filed by)
| Form SCHEDULE 13G/A | |
01/02/2025
11:15 PM | Aptevo Therapeutics (Filer)
| Form EFFECT | |
12/20/2024
3:30 PM | Aptevo Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
12/12/2024
4:15 PM | Aptevo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/12/2024
8:05 AM | Aptevo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/04/2024
7:45 AM | Aptevo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/03/2024
4:05 PM | Aptevo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/26/2024
7:45 AM | Aptevo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/22/2024
7:45 AM | Aptevo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/20/2024
7:45 AM | Aptevo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/08/2024
1:57 PM | Aptevo Therapeutics (Subject)
Hudson Bay Capital Management LP (Filed by)
| Form SC 13G | |
11/07/2024
7:30 AM | Aptevo Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/07/2024
7:15 AM | Aptevo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/25/2024
3:30 PM | Aptevo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/23/2024
3:48 PM | Aptevo Therapeutics (Filer)
| Form PRE 14A | |
09/18/2024
3:07 PM | Aptevo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/17/2024
4:28 PM | Aptevo Therapeutics (Filer)
| Form 424B4 | |
09/16/2024
11:15 PM | Aptevo Therapeutics (Filer)
| Form EFFECT | |
09/16/2024
7:09 AM | Aptevo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/30/2024
4:26 PM | Aptevo Therapeutics (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
08/09/2024
3:30 PM | Aptevo Therapeutics (Issuer)
Taylor Daphne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/09/2024
3:33 PM | Aptevo Therapeutics (Issuer)
Lamothe Jeffrey G. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/09/2024
3:35 PM | Aptevo Therapeutics (Issuer)
Kwon SoYoung (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/08/2024
7:30 AM | Aptevo Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/08/2024
7:15 AM | Aptevo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/07/2024
3:30 PM | Aptevo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/19/2024
3:32 PM | Aptevo Therapeutics (Issuer)
Niederhuber John (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/19/2024
3:34 PM | Aptevo Therapeutics (Issuer)
White Marvin L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/19/2024
3:35 PM | Aptevo Therapeutics (Issuer)
Lamothe Jeffrey G. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/19/2024
3:35 PM | Aptevo Therapeutics (Issuer)
Kwon SoYoung (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/19/2024
3:36 PM | Aptevo Therapeutics (Issuer)
Grant Grady III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/19/2024
3:37 PM | Aptevo Therapeutics (Issuer)
Taylor Daphne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/19/2024
3:38 PM | Aptevo Therapeutics (Issuer)
Harsanyi Zsolt (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/19/2024
3:30 PM | Abdun-Nabi Daniel (Reporting)
Aptevo Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/19/2024
3:31 PM | Aptevo Therapeutics (Issuer)
Kunz Barbara Lopez (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/15/2024
7:19 AM | Aptevo Therapeutics (Filer)
| Form DEF 14A | |
